Bonus Episode | 12 MAY 2021
Emerging Treatments in Atopic Dermatitis
This episode, sponsored by an educational grant from Sanofi Genzyme and Regeneron, is the fourth installment in a five-part series exploring the subject of atopic dermatitis (AD). Hear from Dr Chih-Ho Hong, and Dr Peter Lio, who explore the roles of dupilumab versus emerging Janus kinase (JAK) inhibitor therapies in children, adolescents, and adults with moderate-to-severe AD.
Spotify | Apple | Download MP3 (mp3, 39:10 mins)
